Ionis Pharmaceuticals IONS Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's income tax?
- Ionis Pharmaceuticals (IONS) reported income tax of $218K in Q1 2026.
- How has Ionis Pharmaceuticals's income tax changed year-over-year?
- Ionis Pharmaceuticals's income tax increased by 87.9% year-over-year, from $116K to $218K.
- What is the long-term trend for Ionis Pharmaceuticals's income tax?
- Over 3 years (2022 to 2025), Ionis Pharmaceuticals's income tax has grown at a -46.6% compound annual growth rate (CAGR), from $11.74M to $1.79M.
- What does income tax mean?
- The total amount of tax expense a company owes on its earnings for the period.
- How do you interpret income tax?
- An increase may reflect higher taxable income or changes in tax legislation, while a decrease may indicate tax credits or operating losses.
- How does income tax compare across companies?
- Standard across all public companies; varies based on effective tax rates and geographic footprint.